Emblem, an Ontario based medical cannabis producer, announced in a news release today that Health Canada has granted the company a license to sell cannabis oils.
“Securing this license is an important milestone of our strategy to provide high quality, differentiated cannabis products, in a variety of formats. Our clients will be able to rely upon a selection of cannabis oils, including those from CBD dominant strains, THC dominant strains and strains with both CBD and THC content. Cannabis oils and related formulations provide a level of consistency and dosage accuracy that cannot be achieved with dried flower, and is a substantially more convenient and precise consumption method,” said John H. Stewart, President of Emblem’s Pharmaceutical Division. “We are very excited with the prospects this license brings, as we continue our clinical R&D initiatives towards unique cannabinoid delivery formulations, which we intend to introduce to the market in the future.”
The company said they will announce its updated product offering, later this month, and that sales of its full product line, which include a range of cannabis oils, will begin shortly after the announcement.
By Marijuana.Ca Staff